Home  /  Resource Library  /  Long-Term Survival and Gradual Recovery of B Cells in Patients with Refractory Large B Cell Lymphoma Treated with Axicabtagene Ciloleucel (Axi-Cel)

Long-Term Survival and Gradual Recovery of B Cells in Patients with Refractory Large B Cell Lymphoma Treated with Axicabtagene Ciloleucel (Axi-Cel)

ASH 2020: Long term follow up of CAR T-cell therapy Axicabtagene Ciloleucel for treatment of relapsed diffuse large b-cell lymphoma.